Anzeige
Mehr »
Mittwoch, 09.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 914998 | ISIN: BE0003766806 | Ticker-Symbol: IOB
Tradegate
09.09.26 | 08:25
15,260 Euro
-0,26 % -0,040
Branche
Sonstige Technologie
Aktienmarkt
BEL Mid
1-Jahres-Chart
ION BEAM APPLICATIONS SA Chart 1 Jahr
5-Tage-Chart
ION BEAM APPLICATIONS SA 5-Tage-Chart
RealtimeGeldBriefZeit
15,10015,38008:34
15,22015,26008:31

Aktuelle News zur ION BEAM APPLICATIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.09.IBA SA: IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications221Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS...
► Artikel lesen
ION BEAM APPLICATIONS Aktie jetzt für 0€ handeln
27.08.IBA H1 2026 slides: proton therapy drives 66% EBIT jump14
27.08.IBA SA: IBA reports Half Year 2026 results, on track with its improved profitability trajectory308Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance...
► Artikel lesen
14.07.IBA SA: IBA - Regulated information36
30.06.IBA SA: The National Proton Therapy Center of Portugal will be equipped with two IBA ProteusONE solutions25
25.06.IBA SA: IBA to install the first proton therapy center in Brazil in Rio de Janeiro1.039Louvain-La-Neuve, Belgium, June 25, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions...
► Artikel lesen
17.06.Ion Beam Applications: Aktie legt nach Managementumbau um 7 % zu42
17.06.IBA SA: IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend24
17.06.IBA SA: IBA strengthens its leadership team to support its growth596Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine...
► Artikel lesen
10.06.IBA SA: IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy917Louvain-la-Neuve, Belgium, June 10, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for...
► Artikel lesen
08.06.IBA SA: IBA signs contract with a major U.S. academic medical center to install two ProteusONE proton therapy solutions23
01.06.IBA SA: IBA launches Cyclone iKure, a cyclotron designed for industrial scale Astatine-211 production387Louvain-la-Neuve, Belgium - 01 June 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production...
► Artikel lesen
21.05.IBA SA: First quarter 2026 update: starting the year on track, with product innovation progress681Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026. Group Overview...
► Artikel lesen
20.05.IBA SA: IBA launches Rhodotron LITE, a new low-power X-ray accelerator expanding access to sustainable irradiation solutions3
13.05.IBA SA: IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy6
06.05.IBA SA: IBA Introduces myQA StarTrack³ for Fast, High Resolution Linac QA with a Single Detector Setup9
24.04.IBA SA: The top 250 cancer specialists converge in Belgium to push the frontiers of proton therapy20
27.03.Ion Beam Applications SA Full Year Profit Advances39
27.03.Ion Beam Applications SA GAAP EPS of €0.43, revenue of €620.2M37
27.03.IBA SA: IBA delivers strong FY 2025 results with solid execution in all segments1.207Read the entire full-year 2025 results press release here Louvain-la-Neuve, Belgium, 27 March 2026 - IBA (Ion Beam Applications S.A.), today announces its consolidated results of 2025 financial year...
► Artikel lesen
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1